214 related articles for article (PubMed ID: 35123819)
1. Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience.
Reddy D; Peters M; Shah TT; van Son M; Tanaka MB; Huber PM; Lomas D; Rakauskas A; Miah S; Eldred-Evans D; Guillaumier S; Hosking-Jervis F; Engle R; Dudderidge T; Hindley RG; Emara A; Nigam R; McCartan N; Valerio M; Afzal N; Lewi H; Orczyk C; Ogden C; Shergill I; Persad R; Virdi J; Moore CM; Arya M; Winkler M; Emberton M; Ahmed HU
Eur Urol; 2022 Apr; 81(4):407-413. PubMed ID: 35123819
[TBL] [Abstract][Full Text] [Related]
2. A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.
Guillaumier S; Peters M; Arya M; Afzal N; Charman S; Dudderidge T; Hosking-Jervis F; Hindley RG; Lewi H; McCartan N; Moore CM; Nigam R; Ogden C; Persad R; Shah K; van der Meulen J; Virdi J; Winkler M; Emberton M; Ahmed HU
Eur Urol; 2018 Oct; 74(4):422-429. PubMed ID: 29960750
[TBL] [Abstract][Full Text] [Related]
3. Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort.
Dickinson L; Arya M; Afzal N; Cathcart P; Charman SC; Cornaby A; Hindley RG; Lewi H; McCartan N; Moore CM; Nathan S; Ogden C; Persad R; van der Meulen J; Weir S; Emberton M; Ahmed HU
Eur Urol; 2016 Oct; 70(4):668-674. PubMed ID: 26951947
[TBL] [Abstract][Full Text] [Related]
4. Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer.
Kanthabalan A; Peters M; Van Vulpen M; McCartan N; Hindley RG; Emara A; Moore CM; Arya M; Emberton M; Ahmed HU
BJU Int; 2017 Aug; 120(2):246-256. PubMed ID: 28258616
[TBL] [Abstract][Full Text] [Related]
5. Salvage high-intensity focused ultrasound (S-HIFU) for recurrence after primary radiotherapy of prostate cancer.
Long Depaquit T; Campagna J; Bastide C; Baboudjian M; Corral R; Uleri A; Toledano H
Fr J Urol; 2024 Jun; 34(5):102633. PubMed ID: 38547931
[TBL] [Abstract][Full Text] [Related]
6. Oncological Long-term Outcome After Whole-gland High-intensity Focused Ultrasound for Prostate Cancer-21-yr Follow-up.
Bründl J; Osberghaus V; Zeman F; Breyer J; Ganzer R; Blana A; Gierth M; Denzinger S; Burger M; Rosenhammer B
Eur Urol Focus; 2022 Jan; 8(1):134-140. PubMed ID: 33483288
[TBL] [Abstract][Full Text] [Related]
7. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
Pfeiffer D; Berger J; Gross AJ
BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
[TBL] [Abstract][Full Text] [Related]
8. Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes.
Feijoo ER; Sivaraman A; Barret E; Sanchez-Salas R; Galiano M; Rozet F; Prapotnich D; Cathala N; Mombet A; Cathelineau X
Eur Urol; 2016 Feb; 69(2):214-20. PubMed ID: 26164416
[TBL] [Abstract][Full Text] [Related]
9. Whole-gland salvage high-intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy.
Uddin Ahmed H; Cathcart P; Chalasani V; Williams A; McCartan N; Freeman A; Kirkham A; Allen C; Chin J; Emberton M
Cancer; 2012 Jun; 118(12):3071-8. PubMed ID: 22071795
[TBL] [Abstract][Full Text] [Related]
10. An Exploratory Study of Dose Escalation
Huber PM; Afzal N; Arya M; Boxler S; Dudderidge T; Emberton M; Guillaumier S; Hindley RG; Hosking-Jervis F; Leemann L; Lewi H; McCartan N; Moore CM; Nigam R; Odgen C; Persad R; Thalmann GN; Virdi J; Winkler M; Ahmed HU
J Endourol; 2020 Jun; 34(6):641-646. PubMed ID: 32253928
[No Abstract] [Full Text] [Related]
11. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
[TBL] [Abstract][Full Text] [Related]
13. High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.
Dason S; Wong NC; Allard CB; Hoogenes J; Orovan W; Shayegan B
Int Braz J Urol; 2018; 44(2):248-257. PubMed ID: 29211405
[TBL] [Abstract][Full Text] [Related]
14. Development and internal validation of prediction models for biochemical failure and composite failure after focal salvage high intensity focused ultrasound for local radiorecurrent prostate cancer: Presentation of risk scores for individual patient prognoses.
Peters M; Kanthabalan A; Shah TT; McCartan N; Moore CM; Arya M; van der Voort van Zyp JR; Moerland MA; Hindley RG; Emberton M; Ahmed HU
Urol Oncol; 2018 Jan; 36(1):13.e1-13.e10. PubMed ID: 28927782
[TBL] [Abstract][Full Text] [Related]
15. Salvage high-intensity focused ultrasound for locally recurrent prostate cancer after low-dose-rate brachytherapy: oncological and functional outcomes.
Hostiou T; Gelet A; Chapelon JY; Rouvière O; Mège-Lechevalier F; Lafon C; Tonoli-Catez H; Badet L; Crouzet S
BJU Int; 2019 Nov; 124(5):746-757. PubMed ID: 31148367
[TBL] [Abstract][Full Text] [Related]
16. Focal therapy with high-intensity focused ultrasound for prostate cancer: 3-year outcomes from a prospective trial.
Kaufmann B; Raess E; Schmid FA; Bieri U; Scherer TP; Elleisy M; Donati OF; Rupp NJ; Moch H; Gorin MA; Mortezavi A; Eberli D
BJU Int; 2024 Apr; 133(4):413-424. PubMed ID: 37897088
[TBL] [Abstract][Full Text] [Related]
17. Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy.
Murota-Kawano A; Nakano M; Hongo S; Shoji S; Nagata Y; Uchida T
BJU Int; 2010 Jun; 105(12):1642-5. PubMed ID: 19922544
[TBL] [Abstract][Full Text] [Related]
18. Medium-term Oncological Efficacy and Patient-reported Outcomes After Focal High-intensity Focused Ultrasound: The FOXPRO Trial.
Westhoff N; Ernst R; Kowalewski KF; Derigs F; Neuberger M; Nörenberg D; Popovic ZV; Ritter M; Stephan Michel M; von Hardenberg J
Eur Urol Focus; 2023 Mar; 9(2):283-290. PubMed ID: 36344395
[TBL] [Abstract][Full Text] [Related]
19. Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry.
Shah TT; Peters M; Eldred-Evans D; Miah S; Yap T; Faure-Walker NA; Hosking-Jervis F; Thomas B; Dudderidge T; Hindley RG; McCracken S; Greene D; Nigam R; Valerio M; Minhas S; Winkler M; Arya M; Ahmed HU
Eur Urol; 2019 Jul; 76(1):98-105. PubMed ID: 30638633
[TBL] [Abstract][Full Text] [Related]
20. Focal Treatment for Unilateral Prostate Cancer Using High-Intensity Focal Ultrasound: A Comprehensive Study of Pooled Data.
Albisinni S; Mélot C; Aoun F; Limani K; Peltier A; Rischmann P; van Velthoven R
J Endourol; 2018 Sep; 32(9):797-804. PubMed ID: 29790383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]